glp 1 for multiple sclerosis GLP-1s and glp 1 multiple sclerosis The

Its not a formally recognized clinical protocol and should be used only under provider supervision

To use it optimally, always discuss it with your treating physician

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are gaining increasing attention as first-line agents for the treatment of diabetes and obesity, and with their potential to improve the muscle mass and function, they provide new ideas for the treatment of sarcopenia

Studies in animal colitis models show that BPC-157 may protect the lining of the stomach and intestines and reduce inflammatory damage, supporting mucosal healing in conditions resembling colitis and gastritis

85 JudsonM